Ion Exchange reported a weaker FY26 performance as engineering project delays and rising raw material costs pressured margins. However, a ₹2,338 crore order book and potential for export growth from its new Roha facility provide a pathway for recovery. Investors are now focusing on the company's ability to normalize project execution and improve profitability in the coming quarters.
What Happened
Ion Exchange, a major player in the water treatment industry, reported a challenging financial year for FY26. The company saw a decline in operational performance, driven largely by setbacks in its engineering and chemicals divisions. The engineering segment, which is a core part of its business, faced delays in project completion, partly due to logistics and geopolitical disruptions in the West Asia region. Additionally, the chemicals division dealt with higher-than-expected raw material costs and the initial expenses involved in scaling up operations at its newly expanded Roha manufacturing facility.
Why Financials Came Under Pressure
The dip in performance was most visible in the engineering segment, where EBIT margins dropped to 3.8% in the fourth quarter of FY26, compared to 7.4% during the same period in the previous year. This margin compression highlights how sensitive the business is to external factors. When raw material costs rise or project timelines stretch due to logistical hurdles, the company’s profitability tends to narrow. The Roha facility, while strategically important for future growth, also added to the cost burden in the short term as the company incurred initial spending before reaching optimal production levels.
Order Book And Future Visibility
Despite the immediate difficulties, the company holds a strong order book of ₹2,338 crore, which is roughly 1.3 times the annual revenue of its engineering segment. This provides clear revenue visibility for the next two years. Furthermore, the company has an active bid pipeline of approximately ₹9,500 crore for global industrial and municipal water projects. If secured, these orders could provide significant support to the business in the medium term. The management is also diversifying its revenue by securing predictable, long-term contracts, such as a ₹1,730 crore DBOOT (Design, Build, Own, Operate, Transfer) contract in Oman, which is expected to generate stable cash flows through 2028.
Strategic Export And Operational Outlook
Management expects a recovery in the second half of the current fiscal year. Key factors include the resumption of dispatches to the GCC region, which were previously stalled due to regional conflicts. Additionally, the new Roha resin manufacturing facility has received WQA certification, allowing Ion Exchange to target premium export markets in the US, Europe, and the UK. The company is targeting 25% capacity utilization at this plant in its first full year. As supply chain issues ease and price increases are implemented in the chemicals business, the company aims to improve its earnings profile.
What Investors May Track Next
While the long-term fundamentals of the water treatment sector remain supported by stricter environmental regulations and the demand for zero-liquid discharge solutions, near-term risks persist. Investors may track the speed at which the engineering segment recovers its margins and whether the company can successfully ramp up utilization at the Roha facility. The ability to execute the existing order book without further delays, particularly in international markets, will be an important metric for evaluating the company's operational recovery in the coming quarters.